214 related articles for article (PubMed ID: 16757300)
1. Development of humanized mice for the study of hepatitis C virus infection.
Turrini P; Sasso R; Germoni S; Marcucci I; Celluci A; Di Marco A; Marra E; Paonessa G; Eutropi A; Laufer R; Migliaccio G; Padron J
Transplant Proc; 2006 May; 38(4):1181-4. PubMed ID: 16757300
[TBL] [Abstract][Full Text] [Related]
2. Ultra-rapid cardiotoxicity of the hepatitis C virus protease inhibitor BILN 2061 in the urokinase-type plasminogen activator mouse.
Vanwolleghem T; Meuleman P; Libbrecht L; Roskams T; De Vos R; Leroux-Roels G
Gastroenterology; 2007 Oct; 133(4):1144-55. PubMed ID: 17919490
[TBL] [Abstract][Full Text] [Related]
3. Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera.
Meuleman P; Libbrecht L; De Vos R; de Hemptinne B; Gevaert K; Vandekerckhove J; Roskams T; Leroux-Roels G
Hepatology; 2005 Apr; 41(4):847-56. PubMed ID: 15791625
[TBL] [Abstract][Full Text] [Related]
4. Factors determining successful engraftment of hepatocytes and susceptibility to hepatitis B and C virus infection in uPA-SCID mice.
Vanwolleghem T; Libbrecht L; Hansen BE; Desombere I; Roskams T; Meuleman P; Leroux-Roels G
J Hepatol; 2010 Sep; 53(3):468-76. PubMed ID: 20591528
[TBL] [Abstract][Full Text] [Related]
5. The human liver-uPA-SCID mouse: a model for the evaluation of antiviral compounds against HBV and HCV.
Meuleman P; Leroux-Roels G
Antiviral Res; 2008 Dec; 80(3):231-8. PubMed ID: 18706933
[TBL] [Abstract][Full Text] [Related]
6. A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections.
Kosaka K; Hiraga N; Imamura M; Yoshimi S; Murakami E; Nakahara T; Honda Y; Ono A; Kawaoka T; Tsuge M; Abe H; Hayes CN; Miki D; Aikata H; Ochi H; Ishida Y; Tateno C; Yoshizato K; Sasaki T; Chayama K
Biochem Biophys Res Commun; 2013 Nov; 441(1):230-5. PubMed ID: 24140055
[TBL] [Abstract][Full Text] [Related]
7. Critical role of natural killer cells in the rejection of human hepatocytes after xenotransplantation into immunodeficient mice.
Kawahara T; Douglas DN; Lewis J; Lund G; Addison W; Tyrrell DL; Churchill TA; Kneteman NM
Transpl Int; 2010 Sep; 23(9):934-43. PubMed ID: 20180929
[TBL] [Abstract][Full Text] [Related]
8. Human hepatocytes secrete soluble CD14, a process not directly influenced by HBV and HCV infection.
Meuleman P; Steyaert S; Libbrecht L; Couvent S; Van Houtte F; Clinckspoor F; de Hemptinne B; Roskams T; Vanlandschoot P; Leroux-Roels G
Clin Chim Acta; 2006 Apr; 366(1-2):156-62. PubMed ID: 16253217
[TBL] [Abstract][Full Text] [Related]
9. Human hepatoma HepaRG cell line engraftment in severe combined immunodeficient × beige mice using mouse-specific anti-Fas antibody.
Jiang L; Li JG; Lan L; Wang YM; Mao Q; You JP
Transplant Proc; 2010 Nov; 42(9):3773-8. PubMed ID: 21094855
[TBL] [Abstract][Full Text] [Related]
10. Practical evaluation of a mouse with chimeric human liver model for hepatitis C virus infection using an NS3-4A protease inhibitor.
Kamiya N; Iwao E; Hiraga N; Tsuge M; Imamura M; Takahashi S; Miyoshi S; Tateno C; Yoshizato K; Chayama K
J Gen Virol; 2010 Jul; 91(Pt 7):1668-77. PubMed ID: 20164258
[TBL] [Abstract][Full Text] [Related]
11. Liver-stage development of Plasmodium falciparum, in a humanized mouse model.
Morosan S; Hez-Deroubaix S; Lunel F; Renia L; Giannini C; Van Rooijen N; Battaglia S; Blanc C; Eling W; Sauerwein R; Hannoun L; Belghiti J; Brechot C; Kremsdorf D; Druilhe P
J Infect Dis; 2006 Apr; 193(7):996-1004. PubMed ID: 16518762
[TBL] [Abstract][Full Text] [Related]
12. Establishment of a humanized model of liver using NOD/Shi-scid IL2Rgnull mice.
Suemizu H; Hasegawa M; Kawai K; Taniguchi K; Monnai M; Wakui M; Suematsu M; Ito M; Peltz G; Nakamura M
Biochem Biophys Res Commun; 2008 Dec; 377(1):248-52. PubMed ID: 18840406
[TBL] [Abstract][Full Text] [Related]
13. Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus.
Dandri M; Burda MR; Török E; Pollok JM; Iwanska A; Sommer G; Rogiers X; Rogler CE; Gupta S; Will H; Greten H; Petersen J
Hepatology; 2001 Apr; 33(4):981-8. PubMed ID: 11283864
[TBL] [Abstract][Full Text] [Related]
14. Propagation of Human Hepatocytes in uPA/SCID Mice: Producing Chimeric Mice with Humanized Liver.
Ohshita H; Tateno C
Methods Mol Biol; 2017; 1506():91-100. PubMed ID: 27830547
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein profiles in SCID/uPA mice transplanted with human hepatocytes become human-like and correlate with HCV infection success.
Steenbergen RH; Joyce MA; Lund G; Lewis J; Chen R; Barsby N; Douglas D; Zhu LF; Tyrrell DL; Kneteman NM
Am J Physiol Gastrointest Liver Physiol; 2010 Oct; 299(4):G844-54. PubMed ID: 20651006
[TBL] [Abstract][Full Text] [Related]
16. Generation of humanized animal livers using embryoid body-derived stem cell transplant.
Locke JE; Sun Z; Warren DS; Sheets TP; Holzer H; Shamblott MJ; Montgomery RA; Cameron AM
Ann Surg; 2008 Sep; 248(3):487-93. PubMed ID: 18791369
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus replication in mice with chimeric human livers.
Mercer DF; Schiller DE; Elliott JF; Douglas DN; Hao C; Rinfret A; Addison WR; Fischer KP; Churchill TA; Lakey JR; Tyrrell DL; Kneteman NM
Nat Med; 2001 Aug; 7(8):927-33. PubMed ID: 11479625
[TBL] [Abstract][Full Text] [Related]
18. Near completely humanized liver in mice shows human-type metabolic responses to drugs.
Tateno C; Yoshizane Y; Saito N; Kataoka M; Utoh R; Yamasaki C; Tachibana A; Soeno Y; Asahina K; Hino H; Asahara T; Yokoi T; Furukawa T; Yoshizato K
Am J Pathol; 2004 Sep; 165(3):901-12. PubMed ID: 15331414
[TBL] [Abstract][Full Text] [Related]
19. Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes.
Sugiyama M; Tanaka Y; Kurbanov F; Maruyama I; Shimada T; Takahashi S; Shirai T; Hino K; Sakaida I; Mizokami M
Gastroenterology; 2009 Feb; 136(2):652-62.e3. PubMed ID: 19041311
[TBL] [Abstract][Full Text] [Related]
20. Chronic infection with hepatitis B viruses and antiviral drug evaluation in uPA mice after liver repopulation with tupaia hepatocytes.
Dandri M; Burda MR; Zuckerman DM; Wursthorn K; Matschl U; Pollok JM; Rogiers X; Gocht A; Köck J; Blum HE; von Weizsäcker F; Petersen J
J Hepatol; 2005 Jan; 42(1):54-60. PubMed ID: 15629507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]